Cellectis S.A. (EPA:ALCLS)
France · Delayed Price · Currency is EUR 3.570
+0.022 (0.62%)
May 14, 2026, 5:35 PM CET
Cellectis Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 68.07 | 72.95 | 41.51 | 0.76 | 19.17 | 30.35 |
Other Revenue | 7.04 | 6.64 | 7.71 | 8.44 | 6.55 | 8.25 |
| 75.11 | 79.59 | 49.22 | 9.19 | 25.72 | 38.6 | |
Revenue Growth (YoY) | 37.20% | 61.72% | 435.38% | -64.26% | -33.35% | -35.20% |
Cost of Revenue | - | - | - | 0.74 | 1.77 | 1.84 |
Gross Profit | 75.11 | 79.59 | 49.22 | 8.46 | 23.95 | 36.75 |
Selling, General & Admin | 20.68 | 19.79 | 19.09 | 16.81 | 17.49 | 22.88 |
Research & Development | 98.77 | 93.52 | 90.54 | 87.65 | 97.5 | 117.84 |
Other Operating Expenses | -0.28 | -0.64 | -0.85 | 0.1 | -1.38 | -0.49 |
Operating Expenses | 119.18 | 112.67 | 108.77 | 104.56 | 113.62 | 140.23 |
Operating Income | -44.06 | -33.08 | -59.56 | -96.1 | -89.67 | -103.48 |
Interest Expense | -2.31 | -8.11 | -7.45 | -5.31 | -3.79 | -4.17 |
Interest & Investment Income | 9.5 | 9.5 | 11.28 | 3.61 | 1.12 | 0.72 |
Currency Exchange Gain (Loss) | -22.06 | -22.06 | 7.33 | 4.22 | 6.06 | 9.74 |
Other Non Operating Income (Expenses) | -8.68 | -14.27 | 11.64 | -21.69 | -12.33 | 0.44 |
EBT Excluding Unusual Items | -67.61 | -68.02 | -36.76 | -115.26 | -98.6 | -96.75 |
Legal Settlements | - | - | - | -1.2 | - | - |
Pretax Income | -67.61 | -68.02 | -36.76 | -116.46 | -98.6 | -96.75 |
Income Tax Expense | -0.38 | -0.42 | - | 0.37 | 0.09 | - |
Earnings From Continuing Operations | -67.23 | -67.59 | -36.76 | -116.84 | -98.69 | -96.75 |
Earnings From Discontinued Operations | - | - | - | 8.39 | -15.35 | -28.36 |
Net Income to Company | -67.23 | -67.59 | -36.76 | -108.44 | -114.03 | -125.11 |
Minority Interest in Earnings | - | - | - | 7.38 | 7.89 | 10.91 |
Net Income | -67.23 | -67.59 | -36.76 | -101.06 | -106.14 | -114.2 |
Net Income to Common | -67.23 | -67.59 | -36.76 | -101.06 | -106.14 | -114.2 |
Shares Outstanding (Basic) | 100 | 100 | 91 | 57 | 46 | 45 |
Shares Outstanding (Diluted) | 100 | 100 | 91 | 57 | 46 | 45 |
Shares Change (YoY) | 2.78% | 10.72% | 58.85% | 25.17% | 1.62% | 5.45% |
EPS (Basic) | -0.67 | -0.67 | -0.41 | -1.77 | -2.33 | -2.55 |
EPS (Diluted) | -0.67 | -0.67 | -0.41 | -1.77 | -2.33 | -2.55 |
Free Cash Flow | -39.88 | -41.76 | 20.41 | -25.82 | -89.88 | -123.11 |
Free Cash Flow Per Share | -0.40 | -0.42 | 0.23 | -0.45 | -1.97 | -2.75 |
Gross Margin | 100.00% | 100.00% | 100.00% | 91.98% | 93.11% | 95.22% |
Operating Margin | -58.66% | -41.56% | -121.01% | -1045.38% | -348.57% | -268.11% |
Profit Margin | -89.51% | -84.92% | -74.69% | -1099.30% | -412.61% | -295.87% |
Free Cash Flow Margin | -53.10% | -52.47% | 41.46% | -280.85% | -349.38% | -318.95% |
EBITDA | -33.13 | -21.75 | -48.25 | -86.05 | -79.77 | -98.65 |
EBITDA Margin | -44.11% | -27.33% | -98.04% | - | - | -255.59% |
D&A For EBITDA | 10.93 | 11.33 | 11.3 | 10.06 | 9.9 | 4.83 |
EBIT | -44.06 | -33.08 | -59.56 | -96.1 | -89.67 | -103.48 |
EBIT Margin | -58.66% | -41.56% | -121.01% | - | - | -268.11% |
Revenue as Reported | 75.11 | 79.59 | 49.22 | 9.19 | 25.73 | 38.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.